開潤股份(300577.SZ):子公司擬收購上海嘉樂15.904%股權
格隆匯6月5日丨開潤股份(300577.SZ)公佈,全資子公司滁州米潤科技有限公司擬以募集資金人民幣13,739.01萬元收購安徽省泰合智能出行股權投資合夥企業(有限合夥)持有的上海嘉樂股份有限公司(簡稱“上海嘉樂”)10.9040%股份;擬以自有資金和募集資金人民幣6,300.00萬元收購淮安玖安創業投資合夥企業(有限合夥)持有的上海嘉樂股份有限公司5.0000%股份。本次交易完成後上海嘉樂將成為公司控股子公司,納入公司合併報表範圍,公司主營業務將全面進入紡織服裝及面料生產製造領域,對提升公司發展質量及投資價值起到促進作用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.